Instrumented Interconnecteds Intelligent

Sprengel, Ph.D., Senior Managing Consultant, Life Science and Pharma Practice, IBM Global Business Services

Sprengel, Ph.D., Senior Managing Consultant, Life Science and Pharma Practice, IBM Global Business Services

By Jörg Sprengel, Ph.D.

Each year, tremendous resources are invested in research and development (R&D) to help eradicate or mitigate the devastating effects of rare or incurable illnesses, and inoculate us against the health threats of tomorrow.

Researchers estimate that it takes an average investment of $1.3 billion and more than a decade of work to bring a new pharmaceutical product to market. Yet 60 percent of R&D projects fail to bring a new products and treatments to fruition for a variety of reasons. Some fail to meet specific safety criteria, while others are proven ineffective. In other cases, study results are contradictory, making it difficult to verify or replicate findings. And let’s not forget the need for critical regulatory safeguards to test new products for safety and efficacy. In fact, regulation poses a steep threshold for market entry that can sometimes hold investors back from exploring new frontiers and products.

But what if the process could be faster, cheaper, and more efficient?

If we could verify scientific findings with more speed and reliability, we could decrease the time and cost of healthcare R&D. And if we could decrease the time and cost of R&D, we could lower the threshold for companies to investigate new treatments, therapies, and diagnostic tools, ultimately creating more jobs and speeding medical breakthroughs to the patients who are counting on them.

To that end, IBM’s Institute for Business Value recently released new research on a systematic approach to verify scientific findings. The approach creates a trusted, value-based business model based on crowd sourcing that can help innovators mitigate risks, reduce costs and accelerate the timeline to market.

While traditional peer review and empirical evaluation of scientific claims will always play an important role in the medical innovation process, an objective and systematic approach to verify complex scientific findings and claims and confirm safety and efficacy earlier in the R&D process would mean faster ROI for investors, and faster cures for patients.

Healthcare systems and providers seek solutions to provide patients with more holistic, smarter care through integration of critical technologies. Likewise, pharmaceutical companies and medical device manufacturers can leverage the power of big data, analytics and cognitive computing to implement a more reliable, systems-based approach to biological data verification.

The results, we believe, would be healthier patients, and healthier economies.

Bookmark and Share

Previous post

Next post

4 Comments
 
August 6, 2013
3:32 pm

Good way of describing, and fastidious paragraph to get information regarding my presentation topic, which i am going to convey in institution of higher education.|


Posted by: ulimited hosting
 
July 29, 2013
1:25 am

Fabulous post! Very fascinating to read. You really did a great job. Thanks for your time in updating such an informative blog. Keep it up. I am anxiously looking for some new updates.


Posted by: Metagenics
 
July 8, 2013
4:18 am

Hey Jorg, great blog shared above. I think various research work should be done to eradicate incurable diseases. Thanks for sharing your thoughts. Awaiting for more posts like this.


Posted by: Shreya
 
July 2, 2013
7:03 am

Hmm it seems like your blog ate my first comment (it was extremely long) so I guess I’ll just sum it up what I wrote and say, I’m
thoroughly enjoying your blog. I as well am an aspiring blog writer
but I’m still new to everything. Do you have any recommendations for beginner blog writers? I’d genuinely appreciate it.


Posted by: rec solar panels
 
1 Trackback
 
September 2, 2013
6:14 am

[...] også: A smarter approach to verifying scientific claims could save money and help patients Se også: Monitor sends heart patients’ health data to doctors in real [...]


Posted by: Behov for nytænkning på sundhedsområdet: Fra sygdomsleje til sundhedspleje | A Smarter Planet (Denmark)
 
Post a Comment